Effect of tolvaptan in autosomal dominant polycystic kidney disease by CKD stage: results from the TEMPO 3:4 trial

Authors :: Torres, V E
Higashihara, E
Devuyst, O
Chapman, A B
Gansevoort, R T
Grantham, J J
Perrone, R D
Ouyang, J
Blais, J D
Czerwiec, F S
University of Zurich
Torres, V E
Publication Year :: 2016

Subjects :: 2727 Nephrology
2747 Transplantation
570 Life sciences
biology
610 Medicine & health
2706 Critical Care and Intensive Care Medicine
10052 Institute of Physiology
2713 Epidemiology

Tools